Understanding Large Molecule Drug Development: From Biologics to Market
Syner-G
SEPTEMBER 15, 2023
Structure-based drug design has evolved, facilitating the exploration of novel chemical probes and lead compound potency, and molecular docking utilizes target structures to predict interactions and offers simplicity and speed. billion by 2028. Both processes are evolving to enhance product development and output.
59 
Let's personalize your content